vs
Side-by-side financial comparison of COHEN & STEERS, INC. (CNS) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
COHEN & STEERS, INC. is the larger business by last-quarter revenue ($143.8M vs $75.5M, roughly 1.9× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 2.9%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-126.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 8.3%).
Cohen & Steers is an American investment management company. It focuses on investments in real estate securities via real estate investment trusts (REIT) and alternative income via preferred securities.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
CNS vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $143.8M | $75.5M |
| Net Profit | $34.9M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 28.0% | 22.7% |
| Net Margin | 24.3% | — |
| Revenue YoY | 2.9% | 27.7% |
| Net Profit YoY | -23.9% | — |
| EPS (diluted) | $0.67 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $143.8M | $75.5M | ||
| Q3 25 | $141.7M | $54.5M | ||
| Q2 25 | $136.1M | $52.4M | ||
| Q1 25 | $134.5M | $46.0M | ||
| Q4 24 | $139.8M | $59.1M | ||
| Q3 24 | $133.2M | $80.5M | ||
| Q2 24 | $121.7M | $47.1M | ||
| Q1 24 | $122.7M | $43.8M |
| Q4 25 | $34.9M | — | ||
| Q3 25 | $41.7M | $8.8M | ||
| Q2 25 | $36.8M | $5.9M | ||
| Q1 25 | $39.8M | $3.0M | ||
| Q4 24 | $45.8M | — | ||
| Q3 24 | $39.7M | $20.3M | ||
| Q2 24 | $31.8M | $-4.5M | ||
| Q1 24 | $34.0M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | 28.0% | 22.7% | ||
| Q3 25 | 34.5% | 17.6% | ||
| Q2 25 | 31.8% | 12.7% | ||
| Q1 25 | 33.6% | 8.7% | ||
| Q4 24 | 35.3% | 22.6% | ||
| Q3 24 | 33.7% | 27.4% | ||
| Q2 24 | 31.5% | -4.6% | ||
| Q1 24 | 32.8% | -5.3% |
| Q4 25 | 24.3% | — | ||
| Q3 25 | 29.4% | 16.2% | ||
| Q2 25 | 27.1% | 11.2% | ||
| Q1 25 | 29.6% | 6.5% | ||
| Q4 24 | 32.8% | — | ||
| Q3 24 | 29.8% | 25.2% | ||
| Q2 24 | 26.1% | -9.6% | ||
| Q1 24 | 27.7% | -11.0% |
| Q4 25 | $0.67 | $0.26 | ||
| Q3 25 | $0.81 | $0.17 | ||
| Q2 25 | $0.72 | $0.12 | ||
| Q1 25 | $0.77 | $0.06 | ||
| Q4 24 | $0.89 | $0.40 | ||
| Q3 24 | $0.77 | $0.41 | ||
| Q2 24 | $0.63 | $-0.09 | ||
| Q1 24 | $0.68 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $145.5M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $562.0M | $130.3M |
| Total Assets | $876.7M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $145.5M | $97.5M | ||
| Q3 25 | $98.1M | $94.4M | ||
| Q2 25 | $95.4M | $96.0M | ||
| Q1 25 | $65.2M | $93.2M | ||
| Q4 24 | $183.0M | $101.0M | ||
| Q3 24 | $106.5M | $96.7M | ||
| Q2 24 | $122.0M | $96.8M | ||
| Q1 24 | $99.5M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $562.0M | $130.3M | ||
| Q3 25 | $550.3M | $115.3M | ||
| Q2 25 | $528.5M | $104.7M | ||
| Q1 25 | $507.7M | $97.1M | ||
| Q4 24 | $511.7M | $92.1M | ||
| Q3 24 | $491.0M | $71.1M | ||
| Q2 24 | $463.2M | $48.5M | ||
| Q1 24 | $378.9M | $51.0M |
| Q4 25 | $876.7M | $216.3M | ||
| Q3 25 | $801.6M | $202.9M | ||
| Q2 25 | $751.0M | $194.9M | ||
| Q1 25 | $834.9M | $196.2M | ||
| Q4 24 | $812.4M | $213.3M | ||
| Q3 24 | $727.8M | $220.7M | ||
| Q2 24 | $784.1M | $205.0M | ||
| Q1 24 | $680.7M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-120.4M | $14.4M |
| Free Cash FlowOCF − Capex | $-126.4M | $14.4M |
| FCF MarginFCF / Revenue | -87.9% | 19.1% |
| Capex IntensityCapex / Revenue | 4.2% | 0.0% |
| Cash ConversionOCF / Net Profit | -3.45× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-253.6M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-120.4M | $14.4M | ||
| Q3 25 | $55.1M | $9.7M | ||
| Q2 25 | $-67.6M | $14.1M | ||
| Q1 25 | $-108.9M | $3.6M | ||
| Q4 24 | $96.7M | $15.6M | ||
| Q3 24 | $25.6M | $11.0M | ||
| Q2 24 | $31.4M | $1.0M | ||
| Q1 24 | $4.9M | $11.2M |
| Q4 25 | $-126.4M | $14.4M | ||
| Q3 25 | $52.6M | $9.7M | ||
| Q2 25 | $-69.8M | $14.1M | ||
| Q1 25 | $-110.0M | $3.6M | ||
| Q4 24 | $85.0M | $15.6M | ||
| Q3 24 | $24.2M | $11.0M | ||
| Q2 24 | $27.1M | $1.0M | ||
| Q1 24 | $537.0K | — |
| Q4 25 | -87.9% | 19.1% | ||
| Q3 25 | 37.1% | 17.7% | ||
| Q2 25 | -51.3% | 26.8% | ||
| Q1 25 | -81.8% | 7.7% | ||
| Q4 24 | 60.8% | 26.4% | ||
| Q3 24 | 18.2% | 13.7% | ||
| Q2 24 | 22.3% | 2.1% | ||
| Q1 24 | 0.4% | — |
| Q4 25 | 4.2% | 0.0% | ||
| Q3 25 | 1.8% | 0.0% | ||
| Q2 25 | 1.6% | 0.0% | ||
| Q1 25 | 0.8% | 0.1% | ||
| Q4 24 | 8.3% | 0.0% | ||
| Q3 24 | 1.1% | 0.0% | ||
| Q2 24 | 3.5% | 0.0% | ||
| Q1 24 | 3.5% | 0.0% |
| Q4 25 | -3.45× | — | ||
| Q3 25 | 1.32× | 1.10× | ||
| Q2 25 | -1.84× | 2.41× | ||
| Q1 25 | -2.74× | 1.21× | ||
| Q4 24 | 2.11× | — | ||
| Q3 24 | 0.65× | 0.54× | ||
| Q2 24 | 0.99× | — | ||
| Q1 24 | 0.14× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
